The CRF Clinical Trials Center (CTC) has shaped the cardiovascular field by directing some of the most influential and complex trials in recent decades. For more than 20 years, the CTC has contributed to key advances in the treatment of cardiovascular disease and played an essential role in bringing innovative new technologies, pharmacologic therapies, and treatment paradigms to patients.
Track Record of Excellence
MORE THAN 2,000 ARTICLES, PEER REVIEWED ABSTRACTS, AND BOOKS DURING THE PAST DECADE
The scientific rigor for which the Cardiovascular Research Foundation and the Clinical Trials Center are known has led to a track record of publishing that is second to none. CRF faculty have contributed to more than 2,000 articles, peer-reviewed abstracts, and books.
In many instances, this publishing output has generated data and manuscripts for years following the conclusion of the trial. Many CTC trials are showcased at TCT, Cardiovascular Research Foundation’s annual educational meeting and the largest forum devoted to interventional cardiology as well as at other major cardiovascular meetings.
The Clinical Trials Center has shaped the cardiovascular field by directing some of the most influential, complex cardiac trials in recent decades including:
Landmark CRF Clinical Trials
- SPIRIT III
- SPIRIT IV
Pivotal Studies at the CRF Clinical Trials Center Currently in Progress
- ISCHEMIA – primary completion May 2018